BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 38507216)

  • 1. Rapid high-resolution HLA genotyping by MinION Oxford nanopore sequencing for deceased donor organ allocation.
    De Santis D; Truong L; Martinez P; D'Orsogna L
    HLA; 2020 Aug; 96(2):141-162. PubMed ID: 32274854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing nanopore sequencing technology for the rapid and comprehensive characterization of eleven HLA loci; addressing the need for deceased donor expedited HLA typing.
    Mosbruger TL; Dinou A; Duke JL; Ferriola D; Mehler H; Pagkrati I; Damianos G; Mbunwe E; Sarmady M; Lyratzakis I; Tishkoff SA; Dinh A; Monos DS
    Hum Immunol; 2020 Aug; 81(8):413-422. PubMed ID: 32595056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.
    Larkins NG; D'Orsogna L; Taverniti A; Sharma A; Chakera A; Chan D; Krishnan A; Wong G; Lim WH
    Front Immunol; 2022; 13():844438. PubMed ID: 35799779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of assigning 2-field HLA alleles from real-time PCR on deceased donor assessments and conformance with high resolution alleles.
    Hiho S; Bowman S; Hudson F; Sullivan L; Carroll R; Diviney M
    HLA; 2023 Nov; 102(5):570-577. PubMed ID: 37128703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of sequence-specific oligonucleotide probe vs next generation sequencing for HLA-A, B, C, DRB1, DRB3/B4/B5, DQA1, DQB1, DPA1, and DPB1 typing: Toward single-pass high-resolution HLA typing in support of solid organ and hematopoietic cell transplant programs.
    Smith AG; Pereira S; Jaramillo A; Stoll ST; Khan FM; Berka N; Mostafa AA; Pando MJ; Usenko CY; Bettinotti MP; Pyo CW; Nelson WC; Willis A; Askar M; Geraghty DE
    HLA; 2019 Sep; 94(3):296-306. PubMed ID: 31237117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-field resolution on-call HLA typing for deceased donors using nanopore sequencing.
    Devriese M; Da Silva S; Le Mene M; Rouquie J; Allain V; Kolesar L; Rigo K; Creary LE; Lauterbach N; Usureau C; Dewez M; Caillat-Zucman S; Werner G; Taupin JL
    HLA; 2024 Mar; 103(3):e15441. PubMed ID: 38507216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long road/read to rapid high-resolution HLA typing: The nanopore perspective.
    Liu C
    Hum Immunol; 2021 Jul; 82(7):488-495. PubMed ID: 32386782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
    Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
    Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typing of potential and selected donors for transplant: methodology and resolution.
    Oudshoorn M; Horn PA; Tilanus M; Yu N
    Tissue Antigens; 2007 Apr; 69 Suppl 1():10-2. PubMed ID: 17445154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays.
    Tiercy JM; Villard J; Roosnek E
    Transpl Immunol; 2002 Aug; 10(2-3):215-21. PubMed ID: 12216952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular techniques for typing unrelated marrow donors: potential impact of molecular typing disparity on donor selection.
    Baxter-Lowe LA
    Bone Marrow Transplant; 1994; 14 Suppl 4():S42-50. PubMed ID: 7728125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenetic selection of donors for haematopoietic stem cell transplantation: an approach.
    Fischer G
    Transpl Immunol; 2002 Aug; 10(2-3):223-5. PubMed ID: 12216953
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.